The human lung adenocarcinoma cell line EKVX produces an infectious xenotropic murine leukemia virus

Viruses

Volumn 3, Issue 12, 2011, Pages 2442-2461

  Cmarik, Joan L ^a   Troxler, Jami A ^a   Hanson, Charlotte A ^a   Zhang, Xiang ^a   Ruscetti, Sandra K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EKVX; Gammaretrovirus; Human cell line; NCI 60; Xenotropic murine leukemia virus

Indexed keywords

ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CELL STRAIN EKVX; CELL STRAIN LNCAP; CONTROLLED STUDY; DISEASE TRANSMISSION; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MALE; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; RETROVIRUS INFECTION; SEQUENCE HOMOLOGY; TUMOR CELL; VIRUS INFECTIVITY; XENOTROPIC MURINE LEUKEMIA VIRUS;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; GENES, VIRAL; HUMANS; IMMUNOBLOTTING; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; LUNG NEOPLASMS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; SEQUENCE ALIGNMENT; TUMOR VIRUS INFECTIONS; VIRAL ENVELOPE PROTEINS;

EID: 84255204851     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3122442     Document Type: Article

References (97)

1. Shoemaker, R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6, 813-823.
2. Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbott, B.J.; Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589-601.
3. Hackett, A.J.; Smith, H.S.; Springer, E.L.; Owens, R.B.; Nelson-Rees, W.A.; Riggs, J.L.; Gardner, M.B. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J. Natl. Cancer Inst. 1977, 58, 1795-1806.
4. Soule, H.D.; Vazguez, J.; Long, A.; Albert, S.; Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 1973, 51, 1409-1416.
5. Cailleau, R.; Young, R.; Olive, M.; Reeves, W.J., Jr. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 1974, 53, 661-674.
6. Keydar, I.; Chen, L.; Karby, S.; Weiss, F.R.; Delarea, J.; Radu, M.; Chaitcik, S.; Brenner, H.J. Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 1979, 15, 659-670.
7. Cailleau, R.; Olive, M.; Cruciger, Q.V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978, 14, 911-915.
8. Rutka, J.T.; Giblin, J.R.; Dougherty, D.Y.; Liu, H.C.; McCulloch, J.R.; Bell, C.W.; Stern, R.S.; Wilson, C.B.; Rosenblum, M.L. Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol. 1987, 75, 92-103.
9. Rutka, J.T.; Giblin, J.R.; Hoifodt, H.K.; Dougherty, D.V.; Bell, C.W.; McCulloch, J.R.; Davis, R.L.; Wilson, C.B.; Rosenblum, M.L. Establishment and characterization of a cell line from a human gliosarcoma. Cancer Res. 1986, 46, 5893-5902.
10. Gross, J.L.; Behrens, D.L.; Mullins, D.E.; Kornblith, P.L.; Dexter, D.L. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res. 1988, 48, 291-296.
11. Kornblith, P.L.; Smith, B.H.; Leonard, L.A. Response of cultured human brain tumors to nitrosoureas: correlation with clinical data. Cancer 1981, 47, 255-265.
12. CNS cell lines SNB-19 and U251 are derived from the same individual. http://dtp.nci.nih.gov/docs/misc/common_files/U251_SNB-19.html.
13. Bigner, D.D.; Bigner, S.H.; Ponten, J.; Westermark, B.; Mahaley, M.S.; Ruoslahti, E.; Herschman, H.; Eng, L.F.; Wikstrand, C.J. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 1981, 40, 201-229.
14. Semple, T.U.; Quinn, L.A.; Woods, L.K.; Moore, G.E. Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res. 1978, 38, 1345-1355.
15. Brattain, M.G.; Fine, W.D.; Khaled, F.M.; Thompson, J.; Brattain, D.E. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 1981, 41, 1751-1756.
16. Dexter, D.L.; Barbosa, J.A.; Calabresi, P. N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res. 1979, 39, 1020-1025.
17. Fogh, J.; Trempe, G. New human tumor cell lines. In Human Tumor Cells In Vitro, Fogh, J., Ed. Plenum Press: New York, NY, USA, 1975; pp 115-159.
18. Morikawa, K.; Walker, S.M.; Jessup, J.M.; Fidler, I.J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res. 1988, 48, 1943-1948.
19. Leibovitz, A.; Stinson, J.C.; McCombs, W.B., 3rd; McCoy, C.E.; Mazur, K.C.; Mabry, N.D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976, 36, 4562-4569.
20. Foley, G.E.; Lazarus, H.; Farber, S.; Uzman, B.G.; Boone, B.A.; McCarthy, R.E. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965, 18, 522-529.
21. Collins, S.J.; Gallo, R.C.; Gallagher, R.E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977, 270, 347-349.
22. Lozzio, C.B.; Lozzio, B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975, 45, 321-334.
23. Minowada, J.; Onuma, T.; Moore, G.E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 1972, 49, 891-895.
24. Matsuoka, Y.; Moore, G.E.; Yagi, Y.; Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med. 1967, 125, 1246-1250.
25. Beckwith, M.; Urba, W.J.; Longo, D.L. Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15. J. Natl. Cancer Inst. 1993, 85, 483-488.
26. Aamdal, S.; Fodstad, O.; Kaalhus, O.; Pihl, A. Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors. Int. J. Cancer 1986, 37, 579-587.
27. Fodstad, O.; Aamdal, S.; McMenamin, M.; Nesland, J.M.; Pihl, A. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int. J. Cancer 1988, 41, 442-449.
28. Sulit, H.L.; Golub, S.H.; Irie, R.F.; Gupta, R.K.; Grooms, G.A.; Morton, D.L. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects. Int. J. Cancer 1976, 17, 461-468.
29. MDA-MB-435 is a melanoma cell line, not a breast cancer cell line. http://dtp.nci.nih.gov/docs/misc/common_files/mda-mb-435-update.html.
30. Brinkley, B.R.; Beall, P.T.; Wible, L.J.; Mace, M.L.; Turner, D.S.; Cailleau, R.M. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res. 1980, 40, 3118-3129.
31. Rae, J.M.; Creighton, C.J.; Meck, J.M.; Haddad, B.R.; Johnson, M.D. MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat. 2007, 104, 13-19.
32. Carey, T.E.; Takahashi, T.; Resnick, L.A.; Oettgen, H.F.; Old, L.J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 3278-3282.
33. Giard, D.J.; Aaronson, S.A.; Todaro, G.J.; Arnstein, P.; Kersey, J.H.; Dosik, H.; Parks, W.P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 1973, 51, 1417-1423.
34. McLemore, T.L.; Adelberg, S.; Czerwinski, M.; Hubbard, W.C.; Yu, S.J.; Storeng, R.; Wood, T.G.; Hines, R.N.; Boyd, M.R. Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell lines. J. Natl. Cancer Inst. 1989, 81, 1787-1794.
35. McLemore, T.; Alley, M.; Liu, W.; Hubbard, W., Adelberg, S.; Czerwinski, M.; Yu, S.; Stinson, S.; Storeng, R.; Eggleston, J.; Boyd, M. Histopathologic, biochemical and molecular genetic characterization of four newly established human pulmonary carcinoma cell lines. In Proceedings of the American Association for Cancer Research, San Francisco, CA, USA, May 1989; p 225.
36. Carney, D.N.; Gazdar, A.F.; Bepler, G.; Guccion, J.G.; Marangos, P.J.; Moody, T.W.; Zweig, M.H.; Minna, J.D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 1985, 45, 2913-2923.
37. Gazdar, A.F.; Minna, J.D. NCI series of cell lines: an historical perspective. J. Cell. Biochem. Suppl. 1996, 24, 1-11.
38. Falzon, M.; McMahon, J.B.; Gazdar, A.F.; Schuller, H.M. Preferential metabolism of Nnitrosodiethylamine by two cell lines derived from human pulmonary adenocarcinomas. Carcinogenesis 1986, 7, 17-22.
39. Gazdar, A.F.; Linnoila, R.I.; Kurita, Y.; Oie, H.K.; Mulshine, J.L.; Clark, J.C.; Whitsett, J.A. Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res. 1990, 50, 5481-5487.
40. Benard, J.; Da Silva, J.; De Blois, M.C.; Boyer, P.; Duvillard, P.; Chiric, E.; Riou, G. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res. 1985, 45, 4970-4979.
41. Cell Line NCI/ADR-RES is an ovarian tumor cell line, not a breast line. http://dtp.nci.nih.gov/docs/misc/common_files/NCI-ADRres.html.
42. Batist, G.; Tulpule, A.; Sinha, B.K.; Katki, A.G.; Myers, C.E.; Cowan, K.H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem. 1986, 261, 15544-15549.
43. Roschke, A.V.; Tonon, G.; Gehlhaus, K.S.; McTyre, N.; Bussey, K.J.; Lababidi, S.; Scudiero, D.A.; Weinstein, J.N.; Kirsch, I.R. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res. 2003, 63, 8634-8647.
44. Hamilton, T.C.; Young, R.C.; McKoy, W.M.; Grotzinger, K.R.; Green, J.A.; Chu, E.W.; Whang- Peng, J.; Rogan, A.M.; Green, W.R.; Ozols, R.F. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 1983, 43, 5379-5389.
45. Hamilton, T.C.; Young, R.C.; Ozols, R.F. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. Semin. Oncol. 1984, 11, 285-298.
46. Schilder, R.J.; Hall, L.; Monks, A.; Handel, L.M.; Fornace, A.J., Jr.; Ozols, R.F.; Fojo, A.T.; Hamilton, T.C. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int. J. Cancer 1990, 45, 416-422.
47. Stone, K.R.; Mickey, D.D.; Wunderli, H.; Mickey, G.H.; Paulson, D.F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 1978, 21, 274-281.
48. Kaighn, M.E.; Narayan, K.S.; Ohnuki, Y.; Lechner, J.F.; Jones, L.W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol. 1979, 17, 16-23.
49. Borden, E.C.; Hogan, T.F.; Voelkel, J.G. Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells. Cancer Res. 1982, 42, 4948-4953.
50. Berger, D.P.; Winterhalter, B.R.; Fiebig, H.H. Establishment and characterization of human tumor xenografts in thymus-aplastic nude mice. In Immunodeficient Mice in Oncology, Fiebig, H.H.; Berger, D.P., Eds.; Karger: Basel, Switzerland, 1992; Vol. 42, pp 23-46.
51. Naito, S.; von Eschenbach, A.C.; Giavazzi, R.; Fidler, I.J. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 1986, 46, 4109-4115.
52. Bear, A.; Clayman, R.V.; Elbers, J.; Limas, C.; Wang, N.; Stone, K.; Gebhard, R.; Prigge, W.; Palmer, J. Characterization of two human cell lines (TK-10, TK-164) of renal cell cancer. Cancer Res. 1987, 47, 3856-3862.
53. Williams, R.D.; Elliott, A.Y.; Stein, N.; Fraley, E.E. In vitro cultivation of human renal cell cancer. I. Establishment of cells in culture. In Vitro 1976, 12, 623-627.
54. Lasfargues, E.Y.; Coutinho, W.G.; Redfield, E.S. Isolation of two human tumor epithelial cell lines from solid breast carcinomas. J. Natl. Cancer Inst. 1978, 61, 967-978.
55. Urisman, A.; Molinaro, R.J.; Fischer, N.; Plummer, S.J.; Casey, G.; Klein, E.A.; Malathi, K.; Magi-Galluzzi, C.; Tubbs, R.R.; Ganem, D.; et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006, 2, e25.
56. Paprotka, T.; Delviks-Frankenberry, K.A.; Cingoz, O.; Martinez, A.; Kung, H.J.; Tepper, C.G.; Hu, W.S.; Fivash, M.J., Jr.; Coffin, J.M.; Pathak, V.K. Recombinant origin of the retrovirus XMRV. Science 2011, 333, 97-101.
57. van der Kuyl, A.C.; Berkhout, B. XMRV: not a mousy virus. J. Formos. Med. Assoc. 2011, 110, 273-274.
58. Knouf, E.C.; Metzger, M.J.; Mitchell, P.S.; Arroyo, J.D.; Chevillet, J.R.; Tewari, M.; Miller, A.D. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J. Virol. 2009, 83, 7353-7356.
59. Dong, B.; Kim, S.; Hong, S.; Das Gupta, J.; Malathi, K.; Klein, E.A.; Ganem, D.; Derisi, J.L.; Chow, S.A.; Silverman, R.H. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 1655-1660.
60. Hue, S.; Gray, E.R.; Gall, A.; Katzourakis, A.; Tan, C.P.; Houldcroft, C.J.; McLaren, S.; Pillay, D.; Futreal, A.; Garson, J.A.; et al. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010, 7, 111.
61. Wolff, L.; Koller, R.; Ruscetti, S. Monoclonal antibody to spleen focus-forming virus-encoded gp52 provides a probe for the amino-terminal region of retroviral envelope proteins that confers dual tropism and xenotropism. J. Virol. 1982, 43, 472-481.
62. Ono, K.; Satoh, M.; Yoshida, T.; Ozawa, Y.; Kohara, A.; Takeuchi, M.; Mizusawa, H.; Sawada, H. Species identification of animal cells by nested PCR targeted to mitochondrial DNA. In Vitro Cell. Dev. Biol. 2007, 43, 168-175.
63. Oakes, B.; Tai, A.K.; Cingoz, O.; Henefield, M.H.; Levine, S.; Coffin, J.M.; Huber, B.T. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRVlike sequences. Retrovirology 2010, 7, 109.
64. Barrett, T.; Troup, D.B.; Wilhite, S.E.; Ledoux, P.; Evangelista, C.; Kim, I.F.; Tomashevsky, M.; Marshall, K.A.; Phillippy, K.H.; Sherman, P.M.; et al. NCBI GEO: archive for functional genomics data sets--10 years on. Nucleic Acids Res. 2011, 39, D1005-D1010.
65. Kozak, C.A. The mouse "xenotropic" gammaretroviruses and their XPR1 receptor. Retrovirology 2010, 7, 101.
66. Fischer, N.; Schulz, C.; Stieler, K.; Hohn, O.; Lange, C.; Drosten, C.; Aepfelbacher, M. Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg. Infect. Dis. 2010, 16, 1000-1002.
67. Coffin, J.M. Retroviridae: The viruses and their replication. In Fundamental Virology, 3rd ed.; Fields, B.N., Knipe, D.M., Howley, P.M., Eds.; Lippincott-Raven Publishers: Philadelphia, PA, USA, 1996; pp 763-843.
68. Jühling, F.; Mörl, M.; Hartmann, R.K.; Sprinzl, M.; Stadler, P.F.; Pütz, J. tRNAdb 2009: compilation of tRNA sequences and tRNA genes. Nucleic Acids Res. 2009, 37, D159-D162.
69. Jern, P.; Stoye, J.P.; Coffin, J.M. Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet. 2007, 3, 2014-2022.
70. Nikbakht, K.N.; Ou, C.Y.; Boone, L.R.; Glover, P.L.; Yang, W.K. Nucleotide sequence analysis of endogenous murine leukemia virus-related proviral clones reveals primer-binding sites for glutamine tRNA. J. Virol. 1985, 54, 889-893.
71. Ou, C.Y.; Boone, L.R.; Yang, W.K. A novel sequence segment and other nucleotide structural features in the long terminal repeat of a BALB/c mouse genomic leukemia virus-related DNA clone. Nucleic Acids Res. 1983, 11, 5603-5620.
72. Swanstrom, R.; Wills, J.W. Synthesis, Assembly, and Processing of Viral Proteins. In Retroviruses, Coffin, J.M.; Hughes, S.H.; Varmus, H.E., Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 1997; pp 263-341.
73. Frankel, W.N.; Stoye, J.P.; Taylor, B.A.; Coffin, J.M. Genetic analysis of endogenous xenotropic murine leukemia viruses: association with two common mouse mutations and the viral restriction locus Fv-1. J. Virol. 1989, 63, 1763-1774.
74. Hoggan, M.D.; Buckler, C.E.; Sears, J.F.; Rowe, W.P.; Martin, M.A. Organization and stability of endogenous xenotropic murine leukemia virus proviral DNA in mouse genomes. J. Virol. 1983, 45, 473-477.
75. Kozak, C.A.; O'Neill, R.R. Diverse wild mouse origins of xenotropic, mink cell focus-forming, and two types of ecotropic proviral genes. J. Virol. 1987, 61, 3082-3088.
76. O'Neill, R.R.; Khan, A.S.; Hoggan, M.D.; Hartley, J.W.; Martin, M.A.; Repaske, R. Specific hybridization probes demonstrate fewer xenotropic than mink cell focus-forming murine leukemia virus env-related sequences in DNAs from inbred laboratory mice. J. Virol. 1986, 58, 359-366.
77. Tomonaga, K.; Coffin, J.M. Structure and distribution of endogenous nonecotropic murine leukemia viruses in wild mice. J. Virol. 1998, 72, 8289-8300.
78. Aaronson, S.A.; Todaro, G.J.; Scolnick, E.M. Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells. Science 1971, 174, 157-159.
79. Haran-Ghera, N. Leukemogenic activity of centrifugates from irradiated mouse thymus and bone marrow. Int. J. Cancer 1966, 1, 81-87.
80. Hirsch, M.S.; Black, P.H.; Tracy, G.S.; Leibowitz, S.; Schwartz, R.S. Leukemia virus activation in chronic allogeneic disease. Proc. Natl. Acad. Sci. U.S.A. 1970, 67, 1914-1917.
81. Igel, H.J.; Huebner, R.J.; Turner, H.C.; Kotin, P.; Falk, H.L. Mouse leukemia virus activation by chemical carcinogens. Science 1969, 166, 1624-1626.
82. Lieberman, M.; Kaplan, H.S. Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Science 1959, 130, 387-388.
83. Achong, B.G.; Trumper, P.A.; Giovanella, B.C. C-type virus particles in human tumours transplanted into nude mice. Br. J. Cancer 1976, 34, 203-206.
84. Gautsch, J.W.; Knowles, A.F.; Jensen, F.C.; Kaplan, N.O. Highly efficient induction of type C retroviruses by a human tumor in athymic mice. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 2247-2250.
85. Lusso, P.; di Marzo Veronese, F.; Ensoli, B.; Franchini, G.; Jemma, C.; DeRocco, S.E.; Kalyanaraman, V.S.; Gallo, R.C. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 1990, 247, 848-852.
86. Suzuki, T.; Yanagihara, K.; Yoshida, K.; Seido, T.; Kuga, N. Infectious murine type-C viruses released from human cancer cells transplated into nude mice. Gann 1977, 68, 99-106.
87. Todaro, G.J.; Arnstein, P.; Parks, W.P.; Lennette, E.H.; Huebner, R.J. A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc. Natl. Acad. Sci. U.S.A. 1973, 70, 859-862.
88. Tralka, T.S.; Yee, C.L.; Rabson, A.B.; Wivel, N.A.; Stromberg, K.J.; Rabson, A.S.; Costa, J.C. Murine type C retroviruses and intracisternal A-particles in human tumors serially passaged in nude mice. J. Natl. Cancer Inst. 1983, 71, 591-599.
89. Zhang, Y.A.; Maitra, A.; Hsieh, J.T.; Rudin, C.M.; Peacock, C.; Karikari, C.; Brekken, R.A.; Stastny, V.; Gao, B.; Girard, L.; et al. Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol. Ther. 2011, 12.
90. Antoine, M.; Wegmann, B.; Kiefer, P. Envelope and long terminal repeat sequences of an infectious murine leukemia virus from a human SCLC cell line: implications for gene transfer. Virus Genes 1998, 17, 157-168.
91. Raisch, K.P.; Pizzato, M.; Sun, H.Y.; Takeuchi, Y.; Cashdollar, L.W.; Grossberg, S.E. Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. Virology 2003, 308, 83-91.
92. Sfanos, K.S.; Aloia, A.L.; Hicks, J.L.; Esopi, D.M.; Steranka, J.P.; Shao, W.; Sanchez-Martinez, S.; Yegnasubramanian, S.; Burns, K.H.; Rein, A.; et al. Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One 2011, 6, e20874.
93. Jelacic, T.M.; Thompson, D.; Hanson, C.; Cmarik, J.L.; Nishigaki, K.; Ruscetti, S. The tyrosine kinase sf-Stk and its downstream signals are required for maintenance of friend spleen focusforming virus-induced fibroblast transformation. J. Virol. 2008, 82, 419-427.
94. Lombardi, V.C.; Ruscetti, F.W.; Das Gupta, J.; Pfost, M.A.; Hagen, K.S.; Peterson, D.L.; Ruscetti, S.K.; Bagni, R.K.; Petrow-Sadowski, C.; Gold, B.; et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326, 585-589.
95. Drummond, A.J.; Ashton, B.; Buxton, S.; Cheung, M.; Cooper, A.; Heled, J.; Kearse, M.; Moir, R.; Stones-Havas, S.; Sturrock, S.; et al. Geneious v5.1 2010, available from http://www.geneious.com.
96. Goujon, M.; McWilliam, H.; Li, W.; Valentin, F.; Squizzato, S.; Paern, J.; Lopez, R. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 2010, 38, W695-W699.
97. Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; McGettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.; Lopez, R.; et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23, 2947-2948.